Butinib 140 Mg (Ibrutinib) – 30 Capsules

Butinib 140 Mg (Ibrutinib) represents a significant advancement in the realm of blood cancer treatment. The active ingredient, Ibrutinib, is a powerful kinase inhibitor that has revolutionized the approach to managing certain hematologic malignancies.

Butinib 140 mg works by blocking the activity of BTK, a crucial enzyme in the B-cell receptor signaling pathway. By doing so, it interrupts the signals that drive the survival and proliferation of cancerous B cells, offering a targeted and effective treatment for certain blood cancers.

Butinib 140 mg is primarily employed for the treatment of:

• Chronic Lymphocytic Leukemia (CLL): Ibrutinib is prescribed for individuals with CLL, particularly those who have received at least one prior therapy.
• Mantle Cell Lymphoma (MCL): Butinib is indicated for the treatment of MCL in adult patients who have received at least one prior therapy.

Product Feature:

Essential medications for Blood Cancer Treatment, such as Butinib 140 Mg (Ibrutinib), can be procured from Unit Pharmacy!